US to Pay Pfizer Nearly $2B for More Paxlovid Courses in 2023
(Worthy News) – The U.S. government agreed to pay Pfizer Inc nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment Paxlovid, the company said on Tuesday.
The new purchase supplements the 20 million courses previously bought by the United States and are planned for delivery by early 2023, Pfizer said in a statement.
The Biden administration had previously agreed to pay around $10.6 billion – roughly $530 per treatment course – for the first 20 million courses it ordered. They are paying around the same amount per course under the new contract. [ Source: Newsmax (Read More…) ]
💡 Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
📢 Social media algorithms push content further when there’s more engagement — so every 👍 like, 💬 comment, and 🔄 share helps more people discover the truth. 🙌